+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Edema Drug"

From
Retinal Edema - Pipeline Insight, 2024 - Product Thumbnail Image

Retinal Edema - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Global Pulmonary Edema Therapeutics Market 2022-2026 - Product Thumbnail Image

Global Pulmonary Edema Therapeutics Market 2022-2026

  • Report
  • May 2022
  • 120 Pages
  • Global
From
Edema Global Clinical Trials Review, H2, 2019 - Product Thumbnail Image

Edema Global Clinical Trials Review, H2, 2019

  • Clinical Trials
  • December 2019
  • 195 Pages
  • Global
From
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

The Edema Drug market is a subset of the Cardiovascular Drugs market, focusing on drugs used to treat edema, a condition characterized by swelling due to fluid accumulation in the body's tissues. These drugs are used to reduce swelling and improve symptoms such as pain, discomfort, and difficulty breathing. Commonly used edema drugs include diuretics, which reduce the amount of fluid in the body, and vasodilators, which relax the blood vessels and reduce swelling. Other drugs used to treat edema include ACE inhibitors, angiotensin receptor blockers, and calcium channel blockers. The Edema Drug market is highly competitive, with many companies offering a variety of drugs to treat edema. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Other companies in the market include AstraZeneca, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more